Allergy Therapeutics had a revenue of 21.63M in the quarter ending Jun 30, 2024, with -35.58%. This bring the company's revenue in the last twelve months to 55.20M, Decreased 3.64%. In the fiscal year ending Jun 30, 2024, Allergy Therapeutics had annual revenue of 55.20M with -7.36% growth.